Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse MKT  >  InspireMD Inc    

INSPIREMD INC

SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsOfficial PublicationsSector news

INSPIREMD, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 04:53pm EDT

Item 3.01 Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing or Notice of Delisting.

On January 7, 2019, InspireMD, Inc. (the "Company") received notification (the "Deficiency Letter") from the NYSE American LLC ("NYSE American") that the Company is not in compliance with certain NYSE American continued listing standards (the "Listing Standards"). This was in addition to the Company's prior disclosed non-compliance with Sections 1003(a)(ii)-(iii) of the NYSE American Company Guide.

The Deficiency Letter states that the Company's shares of common stock have been selling for a low price per share for a substantial period of time. Pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the NYSE American staff determined that the Company's continued listing is predicated on it effecting a share consolidation or otherwise demonstrating sustained price improvement within a reasonable period of time, which the NYSE American staff determined to be until July 7, 2019. The Company intends to regain compliance with the Listing Standards by undertaking a measure or measures that are for the best interests of the Company and its stockholders.

The Company's common stock will continue to be listed on the NYSE American while it attempts to regain compliance with the Listing Standards, subject to the Company's compliance with other continued listing requirements, as described in prior filings. The Deficiency Letter does not affect the Company's business operations or its Securities and Exchange Commission reporting requirements.


Item 8.01 Other Events.


On January 11, 2019, the Company issued a press release disclosing receipt of the Deficiency Letter from the NYSE American. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits



Exhibit
Number                  Description
99.1        Press release dated January 11, 2019

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INSPIREMD INC
05/15INSPIREMD, INC. : Other Events (form 8-K)
AQ
05/14INSPIREMD, INC. : Results of Operations and Financial Condition, Financial State..
AQ
05/14InspireMD Announces First Quarter 2019 Financial Results
GL
05/13INSPIREMD : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/07InspireMD to Report First Quarter 2019 Financial Results and Provide Business..
GL
04/08INSPIREMD, INC. : Entry into a Material Definitive Agreement, Unregistered Sale ..
AQ
04/05INSPIREMD : Announces Pricing of $2.4 Million Public Offering of Common Stock
AQ
04/04INSPIREMD, INC. : Entry into a Material Definitive Agreement, Unregistered Sale ..
AQ
04/04INSPIREMD : Announces Proposed Public Offering of Common Stock
AQ
04/04InspireMD, Inc. Announces Pricing of $2.4 Million Public Offering of Common S..
GL
More news
Chart INSPIREMD INC
Duration : Period :
InspireMD Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
James J. Barry President, Chief Executive Officer & Director
Paul S. Stuka Chairman
Benzi Spector Head-Operations, Research & Development
Craig Shore Chief Financial Officer, Secretary & Treasurer
Michael L. Berman Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
INSPIREMD INC-19.57%5
MEDTRONIC PLC9.02%125 127
BAXTER INTERNATIONAL INC.24.17%37 732
HOYA CORPORATION24.59%26 026
ZIMMER BIOMET HOLDINGS12.51%23 408
ALIGN TECHNOLOGY31.80%22 667